TERN vs TT · $6.12B cap vs P/E 36, rev $21.32B
Terns Pharmaceuticals Inc (TERN) versus Trane Technologies plc (TT) — a side-by-side from cached financials, not a winner call.
Terns Pharmaceuticals Inc (TERN) is a biotechnology company listed on NASDAQ.
Trane Technologies plc (TT) is a building products & equipment company listed on NYSE.
Latest reported TERN revenue for 2022-12-31 was $0. Net income was -$60.3M. TERN currently screens at market cap $6.12B.
Latest reported TT revenue for 2025-12-31 was $21.32B. Net income was $2.92B. Revenue was up 7.5% from 2024-12-31 to 2025-12-31. TT currently screens at market cap $104.45B and trailing P/E 36.2.
TERN currently screens at market cap $6.12B. TT currently screens at market cap $104.45B and trailing P/E 36.2.
Not investment advice. Open the TERN and TT stock pages for the full models.
Not investment advice.